Latest News

Wednesday, August 23, 2017 | Rosacea, Product Launches and Updates

Colorescience Takes Aim at Rosacea with All Calm™ Clinical Redness Corrector

Colorescience® is introducing All Calm™ Clinical Redness Corrector. Available Colorescience.com, all Calm Clinical Redness Corrector helps neutralize redness with its subtle green un…

Read the full story

Tuesday, August 22, 2017 | Skin Cancer, Product Launches and Updates, Melanoma

Protea Expands Clinical Study for New Melanoma Test

Protea Biosciences Group, Inc. is expanding its clinical research study for their new molecular imaging test for the differential diagnosis of malignant melanoma. The study has now surpassed 250 pa…

Read the full story

Thursday, August 17, 2017 | Skin Care, Research and Publications, La Roche-Posay

Enter Now: La Roche-Posay North American Foundation Calls for Grant Proposals

Calling all dermatology residents, fellows and new practitioners: It’s that time of year again. The La Roche-Posay North American Foundation is accepting submissions for their 2018 program. Gran…

Read the full story

Wednesday, August 16, 2017 | Healthcare Trends, Personnel/Company News

Power Couple: Stroll Health Teams Up With First Derm

Stroll Health and First Derm are partnering to  make dermatology care more accessible and available at a fair price. Stroll's health&…

Read the full story

Wednesday, August 16, 2017 | Research and Publications

Survey Highlights Risks of Pubic Hair Grooming

More than one-quarter of people who groom their pubic hair sustain grooming-related injuries, according to a new article published by JAMA Dermatology. Of the 7,570 men and women who completed…

Read the full story

Wednesday, August 16, 2017 | Skin Care, Skin of Color, Research and Publications

Women of Color May Be Disproportionately Exposed to Beauty Product Chemicals

Women with skin of color have higher levels of beauty-product related chemicals in their bodies compared to white women, according to a commentary published in the American Journal of Obstetrics and G…

Read the full story

Tuesday, August 15, 2017 | Atopic Dermatitis, Skin Care, PuraCap

PuraCap Pharmaceuticals Introduces EpiCeram Quad Pack

PuraCap® Pharmaceutical is introducing the EpiCeram® Controlled Release Skin Barrier Emulsion Quad Pack, which contains four 100-gram airless pumps. EpiCeram® is a US Food and Drug Admi…

Read the full story

Tuesday, August 15, 2017 | Skin Care, Product Launches and Updates, ISDIN

Isdin Launches Nutraseb™ for Facial Seborrheic Dermatitis

Isdin is rolling out Nutraseb™ Facial Cream, a new steroid-free topical Rx for the multi-symptom management of facial seborrhea and seborrheic dermatitis (SD).  Nutraseb™ is a…

Read the full story

Monday, August 14, 2017 | Skin Care, Product Launches and Updates, Revision Skincare

Revision Skincare Launches Nectifirm Advanced

Revision Skincare® is expanding the Nectifirm® collection with Nectifirm® ADVANCED. Nectifirm® ADVANCED harnesses the power of the Microbiome for maintaining skin health.  Acti…

Read the full story

Friday, August 11, 2017 | Rosacea, Research and Publications, National Rosacea Society

Researchers Close in on Cause of Inflammation in Rosacea

Once developed, therapies that block TRPV4 may help treat or prevent inflammation in patients with rosacea, according to new research funded by the National Rosacea Society (NRS). In earlier resear…

Read the full story

Thursday, August 10, 2017 | Skin Cancer, Research and Publications

New Criteria Aims to Help Doctors Spot Amelanotic Melanoma Earlier

New research outlines key features linked to amelanotic melanoma. The findings, which appear in JAMA Dermatology, may help improve detection of this type of melanoma, which is more likely to be dia…

Read the full story

Wednesday, August 09, 2017 | Skin Cancer, Research and Publications

Review Study Suggests Vitamin B3 May Prevent Melanoma

Nicotinamide (Vitamin B3) may help stave off melanoma in high-risk individuals, a new review study suggests. “Nicotinamide has been shown in a clinical trial -- called ONTRAC -- to reduce the…

Read the full story

Wednesday, August 09, 2017 | Fillers & Injectables, Product Launches and Updates, Research and Publications

Bonti’s Novel Gateway Neuromodulator Performs Well in Phase 2A Study

Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profi…

Read the full story

Tuesday, August 08, 2017 | Fungal Infections, Research and Publications

Research on Nitric Oxide-Releasing Nanoparticles Reveals Promising Skin Infection Treatment

George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by der…

Read the full story

Monday, August 07, 2017 | Corporate Lawsuits

Environmental Groups Sue FDA to Take Formaldehyde Out of Salons

The Environmental Working Group (EWG) and Women’s Voices for the Earth (WVE) are suing the Food and Drug Administration (FDA) because of the group’s failure to act on dangerous hair straig…

Read the full story
Load More
 Stock Price  Change 
 AbbVie $71.52  -0.32% 
 Allergan $222.27  -0.66% 
 Amgen $169.00  -0.63% 
 Bayer AG $127.85  -0.37% 
 Celgene $129.19  -0.84% 
 Cutera $34.90  -0.14% 
 Cynosure $0.00  0.00% 
 GlaxoSmithKline $39.32  0.49% 
 Johnson and Johnson $132.80  -1.41% 
 Lily $78.15  -0.14% 
 Nestle $84.76  -0.27% 
 Novartis $83.28  -0.25% 
 Pfizer $33.24  0.24% 
 Proctor and Gamble $92.44  -0.38% 
 Taro $103.14  -0.32% 
 Unilever $59.00  -0.07% 
 Valeant $14.42  0.49%